<DOC>
	<DOCNO>NCT00147654</DOCNO>
	<brief_summary>The primary objective trial evaluate effect tolterodine ER plus tamsulosin versus placebo patient perception overall treatment benefit men frequency urgency , without urinary urge incontinence ( UUI ) , without bladder outlet obstruction ( BOO ) .</brief_summary>
	<brief_title>Effect Safety Of Detrol LA In Men With Overactive Bladder Symptoms With Or Without Bladder Outlet Obstruction</brief_title>
	<detailed_description />
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Urinary Bladder Neck Obstruction</mesh_term>
	<mesh_term>Tamsulosin</mesh_term>
	<mesh_term>Tolterodine Tartrate</mesh_term>
	<criteria>Male 40 year age Clinical sign symptom frequency urgency , without UUI , without BOO , least three month Mean urinary frequency 8 micturitions/24h verify Screening micturition diary Postvoid residual urine volume ( PVR ) &gt; 200 ml measure ultrasound Maximum urinary flow rate ( Qmax ) &lt; 5 ml/second measure flowmeter ; void volume 75 ml require order accurately record Qmax Prescribed administer antimuscarinic antispasmodic within 1 month Prescribed administer a1adrenergic antagonist within 2 week</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
</DOC>